Prime vendor pharm branch-philadelphia
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DB20D9214
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 1,133 $16,664,241 obligated
Award facts
- Opportunity
-
- SPM2DP13R0007 Solicitation number
- Combined order value
- $16,664,241 Current and potential, with all options
- Last date to order 100% complete
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 contract, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. These products support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.
The delivery orders under this IDC cover a diverse array of specialized pharmaceutical items, such as Xolair, Entyvio, Xtandi, Botox, Nucala, Mirena, and Nexplanon, among others. There are no set-aside designations associated with the IDC or the individual delivery orders, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple medical product categories. The contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to the Department of Defense's healthcare operations.
Task orders
Show 40 more
Latest 50 of 1,133 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DB20D9214?
SPE2DB20D9214 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2020.
How much is contract SPE2DB20D9214 worth?
Orders under SPE2DB20D9214 have obligated $16,664,241.
How many orders have been placed under contract SPE2DB20D9214?
1,133 orders have been placed under SPE2DB20D9214, the latest on October 31, 2025.
Who can order from contract SPE2DB20D9214?
SPE2DB20D9214 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DB20D9214 competed?
The extent of competition for SPE2DB20D9214 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV